Vita Life Sciences Limited. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vita Life Sciences Limited. with three other
pharmaceutical manufacturers in Australasia:
Pharmaust Limited
(2020
sales of 4.12 million Australian Dollars [US$3.01 million]
),
Blis Technologies Ltd
of NEW ZEALAND
(10.64 million New Zealand Dollars [US$7.50 million]
), and
Noxopharm Ltd
(8.34 million Australian Dollars [US$6.08 million]
of which 100%
was Clinical development).
Sales Analysis.
During the second
quarter of 2021, sales at Vita Life Sciences Limited. totalled
A$25.72 million.
This is
an increase of 16.8%
from the A$22.02 million in sales at the company during the second quarter of 2020.
Vita Life Sciences Limited. reported sales of A$46.48 million (US$33.88 million)
for the
year ending
December of 2020.
This
represents
an
increase of 9.5%
versus 2019, when the company's sales were A$42.45 million.
This was the third consecutive year of growth at Vita Life Sciences Limited..